Breaking News
March 24, 2019 - Hidden differences between pathology of CTE and Alzheimer’s disease discovered
March 24, 2019 - Knowing causative genes of osteoporosis may open door to more effective treatments
March 24, 2019 - Toilet-seat based cardiovascular monitoring system getting ready to begin commercialization
March 24, 2019 - New model for intensive care identifies factors that send ill patients to ICU
March 24, 2019 - Recommendations Issued for HSCT in Multiple Myeloma
March 24, 2019 - Deep brain stimulation provides sustained relief for severe depression
March 24, 2019 - “Statistical significance” may soon be a thing of past?
March 24, 2019 - Researchers track effects of epigenetic marks carried by sperm chromosomes
March 24, 2019 - AHA News: Family Adopts Three Children With Three Different Heart Conditions
March 24, 2019 - Research into opioid painkillers could provide clues for safer drug development
March 23, 2019 - Lung cancer survivor recounts her lifetime struggles
March 23, 2019 - Radial and femoral approach for PCI achieve similar results in terms of survival
March 23, 2019 - Study sheds light on the optimal timing of coronary angiography in NSTEMI patients
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
Nurse-led care can be more successful in managing gout

Nurse-led care can be more successful in managing gout

image_pdfDownload PDFimage_print

Providing nurse-led care for people suffering with the painful, long-term condition gout could lead to an increase in the number of patients sticking to a beneficial treatment plan, a clinical trial has revealed.

The research, led by academics at the University of Nottingham and published in The Lancet, has shown that keeping patients fully informed and involving them in decisions about their care can be more successful in managing gout.

And the study, which was funded by the charity Versus Arthritis, highlights the importance of individualized patient education and engagement to treat the condition.

Professor Michael Doherty, in the University’s Division of Rheumatology, said: “The nurses delivered recommended best practice that includes full patient information and engagement and a treat-to-target strategy for urate-lowering treatment. Once fully informed almost all patients want urate-lowering treatment and continue to take it regularly. This results in gradual elimination of the urate crystals that cause gout and subsequent clinical improvements.

“Although nurses delivered this care, the principles of patient education, treat-to-target urate-lowering strategy, and regular follow-up and monitoring are applicable to any health professional who treats people with gout. Although this takes more time with the patient to start with, long-term this becomes very cost effective.”

Gout is the most common type of inflammatory arthritis, which affects around 2.5 per cent of adults in the UK and which causes episodes (“attacks”) of severe joint inflammation and pain. It is sparked by a persistent high level of uric acid (urate) in the body, causing sodium urate crystals to slowly but continuously form in and around the joints.

Attacks are usually treated with anti-inflammatories like ibuprofen but doctors may prescribe drugs such as allopurinol or febuxostat over the long term for patients who are prone to frequent flare ups.

Gout is the only form of arthritis that can be ‘cured’ in effect through the use of urate-lowering therapies (ULT). The ULT dose needs to be adjusted against the blood urate level until a target low level is achieved, this then prevents new crystals from forming and slowly dissolves away the crystals that are there. Patients can also make lifestyle changes if appropriate, such as losing weight if overweight, which can help to bring down urate levels and have other general health benefits.

However, currently only 40 per cent of gout patients ever receive ULT, usually at a fixed dose rather than gradually increasing the dose until a target level of urate is reached in the blood. And getting patients to stick to their medication is tricky.

A previous ‘proof of concept’ study suggested that when people with gout are fully-informed and involved in the decisions around managing their illness, more than nine out of ten wished to have ULT treatment and subsequent adherence to their medication over one year was excellent.

This led to the latest two-year randomised controlled clinical trial in the community to directly compare nurse-led care to the usual GP-led care.

More than 500 gout patients were recruited and randomly split between the two methods of management through more than 50 general practices in the East Midlands. They were followed up at one and two years and assessed for a series of outcomes including the level of urate in their blood, the frequency of gout flare ups and the presence of tophi – firm, white lumps below the surface of the skin caused by a mass of urate crystals.

The research nurses had received training about gout and its management, which reflected current recommendations, and delivered an individualised package of care. This included a holistic assessment, a discussion of perceptions about the illness, full information about gout e.g its causes, consequences and treatment options, and patient involvement in shared decision-making.

The study found that nurse-led care was associated with a much higher take up of ULT, with patients subsequently being more likely to stick to their treatment. At two years, 96 per cent of the nurse-led group were on ULT, compared to 56 per cent in the usual care group.

And 95 per cent of patients had urate levels in the blood below the required target level, compared to just 30 per cent in the GP-led group.

In addition, it revealed that around 400-500mg of allopurinol per day was the dose needed to achieve the right level of urate in the blood, which is more than the top dose of 300mg per day prescribed by most UK doctors.

The nurse-led care significantly reduced flare-up frequency, reduced tophi and improved quality of life and was more cost effective too, saving the NHS money after five years.

Stephen Simpson, Director of Research at Versus Arthritis, said: “Despite national guidelines on how to manage gout effectively, we know that many patients fail to receive any clear explanation of the condition or lifestyle advice to prevent recurring attacks, with few even receiving the appropriate drug treatment. As the most common inflammatory form of arthritis, affecting one in every 100 people, this is not good enough.

“Currently, constraints on GP’s time mean patients are not fully aware of the benefits that come with taking their treatments. The patient-centred approach led by nurses in this study offers a convincing alternative that will not only help to alleviate problems in the long term but will also improve that person’s quality of life.

We are optimistic that if the methods of treatment used in this study are incorporated into national guidelines for GPs we will see a much more effective long-term management of gout, an improvement in the quality of life a person has after an attack, as well reducing healthcare costs over time.”

The Nottingham team worked in collaboration with academics in Health Economics and Decision Science at the University of Sheffield and received invaluable advice from the Nottingham Rheumatology Patient and Public Involvement group during the development of the study. The Nottingham team now plan to examine the feasibility of training existing Practice nurses to see if this results in equally good results. NICE is currently planning to develop UK Guidelines for Management of Gout and it is hoped that the principles used in this study will be incorporated into their guideline to GPs and other health practitioners who manage people with gout.

Source:

https://www.nottingham.ac.uk/news/pressreleases/2018/october/nurse-led-care-significantly-more-successful-in-treating-gout-trial-reveals.aspx

Tagged with:

About author

Related Articles